Noveris Health Sciences is trading at CA$0.33, down -5.80%, after no new company-specific announcement or confirmed catalyst was identified for August 12, 2026.
- The decline follows a volatile sequence, including a 16.87% drop on August 11 and 20.29% gain on August 10.
- Broader markets are higher, so macro strength does not explain the decline; prior management commentary indicated no known material operational change.